These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16076089)

  • 1. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
    Dolznig H; Schweifer N; Puri C; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
    Cancer Immun; 2005 Aug; 5():10. PubMed ID: 16076089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of stromal cell markers in distinct compartments of human skin cancers.
    Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
    J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Fujikawa H; Matsusita K; Kawamura M; Inoue Y; Miki C; Kusunoki M
    Int J Oncol; 2011 Mar; 38(3):655-63. PubMed ID: 21240461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
    Ge Y; Zhan F; Barlogie B; Epstein J; Shaughnessy J; Yaccoby S
    Br J Haematol; 2006 Apr; 133(1):83-92. PubMed ID: 16512833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser capture microdissection of epithelial cancers guided by antibodies against fibroblast activation protein and endosialin.
    Rupp C; Dolznig H; Puri C; Schweifer N; Sommergruber W; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
    Diagn Mol Pathol; 2006 Mar; 15(1):35-42. PubMed ID: 16531767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis.
    Rupp C; Dolznig H; Puri C; Sommergruber W; Kerjaschki D; Rettig WJ; Garin-Chesa P
    Cancer Immun; 2006 Jul; 6():10. PubMed ID: 16875435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
    Koperek O; Scheuba C; Puri C; Birner P; Haslinger C; Rettig W; Niederle B; Kaserer K; Garin Chesa P
    Int J Oncol; 2007 Jul; 31(1):59-67. PubMed ID: 17549405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
    Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
    Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
    Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S
    FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
    Rettig WJ; Garin-Chesa P; Healey JH; Su SL; Ozer HL; Schwab M; Albino AP; Old LJ
    Cancer Res; 1993 Jul; 53(14):3327-35. PubMed ID: 8391923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer vascular targets: endosialin (review).
    Teicher BA
    Int J Oncol; 2007 Feb; 30(2):305-12. PubMed ID: 17203210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.
    Christian S; Winkler R; Helfrich I; Boos AM; Besemfelder E; Schadendorf D; Augustin HG
    Am J Pathol; 2008 Feb; 172(2):486-94. PubMed ID: 18187565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
    Scanlan MJ; Raj BK; Calvo B; Garin-Chesa P; Sanz-Moncasi MP; Healey JH; Old LJ; Rettig WJ
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5657-61. PubMed ID: 7911242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
    Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
    Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
    Goscinski MA; Suo Z; Flørenes VA; Vlatkovic L; Nesland JM; Giercksky KE
    Ultrastruct Pathol; 2008; 32(3):89-96. PubMed ID: 18570153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
    BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.